



Identification and Characterization of a Virulence-








Supervising Professor:   Dr. Shelley Payne  
 
_______________________________ 
      Signature     Date 
 
 
Honors/Dean’s Scholar Advisor: Dr. Shelley Payne  
 
_______________________________ 








I would like to thank Nicola Davies and Erin Murphy for their mentoring, patience, and 
help – you truly impacted both the person and the scientist I have become.  I would also like to 
thank Dr. Shelley Payne for the opportunity to work and learn in her lab as well as for countless 
advice and help throughout my undergraduate years.  Finally I would like to thank my parents 
for fostering my appreciation for science and supporting me throughout the years. 
 
 iii
Shigella species, including Shigella dysenteriae, are causative agents of bacillary 
dysentery, a disease characterized by severe diarrhea and blood in the stool. Although a number 
of genes required for virulence have been characterized in S. dysenteriae, others remain to be 
identified.  These additional virulence-associated genes can be identified by screening mutants of 
S. dysenteriae in a plaque assay.  The plaque assay is used to infer virulence by measuring the 
ability of the bacteria to invade, grow within, and spread between eukaryotic cells, resulting in 
the formation of plaques, small holes in a monolayer of eukaryotic cells.  Mutants that have lost 
the ability to form normal plaques are necessarily avirulent. 
A previously described non-directed mutant, SDU380, lost the ability to form plaques.  
Further characterization revealed that this strain had sustained a 33 kilobase deletion.  None of 
the genes in the deleted region are known virulence genes.  The purpose of this study was to 
identify and characterize a novel virulence gene in this deleted region that resulted in the 
inability of SDU380 to form plaques.  Different mutant strains missing only some of the genes 
deleted in SDU380 were constructed and tested for virulence in a plaque assay.  This analysis 
revealed that the loss of the gene yciB is responsible for the failure of SDU380 to form plaques.  
The role of the protein YciB in S. dysenteriae virulence is unknown, though the yciB gene is a 
known virulence-associated gene in Shigella flexneri, a species with a similar lifestyle to that of 
S. dysenteriae.  In S. flexneri, YciB plays a role in septation, an essential step in cell division.  
Further analysis showed that loss of YciB in S. dysenteriae also results in an intracellular growth 
defect.  However, this defect does not seem to be due to loss of ability to undergo septation and 
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A. General Background 
Shigellosis, infection with Shigella species, is the major type of bacillary dysentery, a 
disease caused by bacteria and characterized by severe diarrhea and blood in the stool (7, 12, 
15).  It causes approximately 1.1 million deaths worldwide each year (7).  Shigellosis affects 
primarily children under the age of five and, with about 164 million cases a year, is endemic in 
developing countries (2, 15).  Due to increased antibiotics resistance of Shigella species, the 
World Health Organization has prioritized vaccine development against Shigella dysenteriae and 
Shigella flexneri, two of four Shigella species (7, 15). 
Humans are the only natural host of Shigellae (7, 15, 19).  The bacteria can only be 
transmitted via the fecal oral route, either through direct contact or through contaminated food or 
water (15, 16).  The prevalence of shigellosis in developing countries is therefore thought to be 
attributable to poor hygiene and poor sanitation (7). 
Shigellae are gram negative bacteria, a classification based on staining characteristics, 
and are closely related to Escherichia coli (15).  The genus Shigella includes four species, 
Shigella flexneri, Shigella boydii, Shigella sonnei and Shigella dysenteriae (7).  Shigella 
dysenteriae is responsible for shigellosis epidemics in developing countries (15).  It causes a 
particularly severe form of shigellosis through the production of Shiga toxin, a substance that 
causes a disease called hemolytic uremic syndrome which may lead to acute kidney failure (15, 
30). Shiga toxin may also cause paralysis (15).  S. flexneri is the predominant endemic species of 
Shigella in developing countries, and S. sonnei is responsible for most Shigella infections in 
industrialized countries (7, 15).  The manifestation of the disease also depends on the immune 
status of the host and the presence of other risk factors such as infection with HIV, further 
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With an infectious dose of only 10 to 100 bacteria, Shigella species are extremely 
virulent (7, 15).  The site of pathogenesis is the human colon, where Shigella infection results in 
inflammation, a non-specific immune response, and destruction of the colon epithelium, a single 
layer of cells facing the lumen (interior) of the colon and acting as a barrier to bacteria (12, 15).  
The destruction of the epithelium leads to the characteristic symptoms of shigellosis, including 
watery diarrhea, abdominal pain, and blood in the stool (7, 19). 
Shigellae are usually ingested via a food or water source and, because they are highly 
acid resistant, can pass undamaged through the stomach and small intestine.  Once in the colon, 
Shigellae go through three stages of pathogenesis: invasion of human colonic epithelial cells, 
replication within these cells, and spread to infect neighboring cells (Fig. 1) (15).  This results in 
the death of host epithelial cells (15).  Genes necessary for these three stages are usually found 
in one of three pathogenicity islands (sections of the chromosome) or on a virulence plasmid (7). 
1. Invasion of epithelium 
Shigellae invade human epithelial cells from the basolateral side (Fig. 1), the side away 
from the lumen (7, 19).  To access the basolateral side of the intestinal epithelium, the bacteria 
cross the epithelial layer through one of three mechanisms. 
! The colonic epithelial layer contains M cells, specialized cells that endocytose (take 
up) samples of the contents of the intestinal lumen and transport these samples to the 
other side of the epithelial layer to a pocket filled with white blood cells, cells of the 
immune system (7).  This arrangement forms an integral part of the immune system, 
as it allows the body to prepare for pathogens before the infection can occur.  
Shigellae, like some other pathogens including Salmonella and Yersinia, are able to 
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take advantage of this system by using M cells to cross the epithelial layer (7, 19).  
Once phagocytosed (taken up) by macrophages (a type of white blood cell) in the 
pocket on the basolateral side of the intestinal epithelium, Shigella turns on genes 
(primarily ipaD) that cause lysis of the phagocytic vacuole and apoptosis (cell death) 
of the macrophage (7).  This results in the bacteria being released into the sub-
mucosa, the space on the basolateral side of the epithelial layer (7).  This is the main 
form of Shigella invasion. 
! Apoptosis of macrophages also induces inflammation, recruiting more cells of the 
immune system to the site of infection (7, 19).  Some of these cells, called PMN cells 
(polymorphonuclear leukocytes), squeeze between the epithelial cells, creating gaps 
in the epithelial layer (7).  Once again, Shigellae take advantage of the host defenses 
by crossing the epithelial layer through the gaps created by the PMN cells (19). 
! Shigellae can also cross the epithelial layer by manipulating proteins in tight 
junctions, structures anchoring adjacent epithelial cells to each other (7).  Thus, the 
bacteria create gaps and cross the epithelial layer independently of the immune 
response system as well. 
Once on the basolateral side of the epithelial layer, Shigellae stimulate epithelial cells to 
engulf them (7, 19).  This is achieved by inducing a rearrangement of the cytoskeletal network 
of filaments that gives structural support to the epithelial cell.  This results in the formation of 
membrane extensions surrounding the bacteria, internalizing the pathogen (7, 19).  To 
accomplish this, Shigellae bind receptors (!5"1 and CD44) on the epithelial cell (19).  These 
receptors are associated with the actin cytoskeleton, suggesting that the initial binding of the 
bacteria to the epithelial cell begins the process of cytoskeleton rearrangement (19).  The 
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receptors are bound by proteins (IpaB-C-D) on the surface of the bacterium (19).  Upon binding 
the bacterium inserts a two-protein complex (IpaB and IpaC) into the epithelial cell membrane, 
forming a pore through which components of a type III secretion system (encoded by the mxi-
spa locus) transport two proteins (IpaA and IpaC) into the epithelial cell (7, 19).  These two 
proteins coordinate the cytoskeleton rearrangement that results in the engulfment of the bacteria 
(7, 19).  Once internalized, Shigellae use IpaB to lyse the membranous vacuole that is formed as 
a result of the engulfing, releasing the bacteria into the host epithelial cell cytoplasm (Fig. 1) 
(19). 
2. Intracellular Replication 
Once inside the host epithelial cell, Shigellae multiply rapidly, doubling in number every 
40 minutes (7).  Replication includes growth of the bacterium, replication of the genetic material 
contained within the bacterium, equal distribution of the replicated genetic material to different 
parts of the cell (binary fission), followed by division (septation) of the bacterium resulting in 
two equivalent daughter cells. 
3. Intracellular and Intercellular Spread 
Shigellae move within the host epithelial cell and into neighboring cells by manipulating 
the host cytoskeletal system (Fig. 1).  Shigellae express and localize a protein (IcsA) to one pole 
of the bacterium, where it interacts with a host protein (N-WASP), stimulating polymerization 
(growth) of actin, a filament of the cytoskeleton system (7).  Actin polymerization on one pole 
of the bacterium propels the bacteria through the interior of the host epithelial cell until it 
encounters the plasma membrane (structure that surrounds each epithelial cell) and forms a 
protrusion into the epithelial cell adjacent to the already infected host cell (7).  This protrusion 
containing Shigellae is endocytosed by the neighboring cell, resulting in a double membraned 
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vesicle containing the bacteria inside this epithelial cell (7).  Once again Shigella lyses the 
membranes of the vacuole it is contained within (IpaB and IpaC mediated) (7).  Free in the new 
host epithelial cell, the bacteria continue to replicate and spread.  
 
Figure 1: Shigella pathogenesis (4) 
1. M-cell dependent invasion of host epithelial layer.  2. Uptake of Shigellae 
by macrophages on the basolateral side of the epithelium.  3. Release of 
Shigellae into the sub-mucosa following Shigellae induced macrophage 
apoptosis.  4. Shigellae stimulated uptake by epithelial cell.  5. Shigellae 
induced evasion of membranous vacuole releasing the bacteria into the host 
cytoplasm.  6. Intracellular and intercellular spread as a result of actin 
polymerization 
 
4. Epithelial cell death 
Cell death or necrosis of host epithelial cells was initially thought to be a result of 
overpacking of Shigellae in host cells due to continuous replication of the bacteria (7). It is now, 
however, thought that the death of host epithelial cells is caused by the inflammatory response of 
the host attacking and killing infected epithelial cells (7).  The destruction of the epithelial layer 












C. Plaque Assay 
Since the only natural host of Shigellae are humans, Shigellae virulence cannot be 
studied using animal models (7, 15, 19).  Virulence can, however, be inferred using the plaque 
assay (Fig. 2 left side) (19).  In this assay, a monolayer of human epithelial cells is infected with 
Shigellae and then incubated for 4 days.  The plaque assay tests the ability of the bacteria to 
invade, grow intracellularly, and spread from cell-to-cell, three essential steps of Shigella 
virulence (7, 15).  If the bacteria are successful in all three of these activities, epithelial cell 
death results in the formation of plaques, small clearings within the monolayer.  A strain that can 
form wild-type (normal) plaques is not necessarily virulent, since other factors, such as 
sensitivity to pH of the stomach, may prevent the bacteria from reaching the colon.  Mutants that 
have lost the ability to form plaques (Fig. 2 right side) are, however, necessarily avirulent as the 
steps required for plaque formation are essential to the pathogenesis of Shigella species (7, 15).   
 
Figure 2:  SDU380, a spontaneous mutant of clinical isolate SDU378, has lost the 
ability to form plaques.
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D. Avirulent strain SDU380 
Though many of the genes involved in Shigella pathogenesis are known, others remain to 
be identified.  To find these genes, Shigella mutants may be screened for loss of the ability to 
form wild-type plaques in the plaque assay and then analyzed to identify virulence-associated 
genes responsible for the mutant phenotype. 
SDU380 is a S. dysenteriae mutant that has lost the ability to form plaques (Fig. 2) (23).  
SDU380 was isolated by selecting for pirazmonam-resistance among spontaneous mutants of 
clinical isolate SDU378 (23).  Pirazmonam is an antibiotic (anti-bacterial agent) that is taken up 
by bacteria using a particular high-affinity iron transport system (TonB).  Once taken up, the 
pirazmonam kills the bacteria (23).  Bacteria that survived pirazmonam treatment must therefore 
have a mutation that prevented pirazmonam uptake.  SDU380 is thus a spontaneous mutant of 
SDU378 that is deficient in TonB function. 
Further analysis of the mutant revealed that SDU380 had sustained a large deletion of 
approximately 33 kilobases, about 1% of the S. dysenteriae genome.  The deleted region spans 
from oppA to yciL and includes tonB, the gene encoding TonB, the oligopeptide permease (opp) 
operon, the tryptophan biosynthesis (trp) operon, the yciCBA operon and a number of 
uncharacterized genes (Fig. 3).  One or more of the genes contained in this deleted region is 





Figure 3: Deleted region in SDU380
 
1. Genes in Deleted Region in order of chromosomal location 
a. Oligopeptide permease (opp) operon 
This operon (series of genes that are co-regulated and code for proteins that usually 
function together) makes up a substantial part of the deletion of SDU380.  It encodes five 
proteins (OppA, OppB, OppC, OppD, OppF) that form a transport system for small peptides 
(10).  As such this operon is important in cell-cell signaling, transport of peptides as carbon and 
nitrogen sources, cell wall component recycling, and many other important bacterial functions 
(9, 20).   
Although no research studies have shown a virulence-associated role of the oligopeptide 
permease system in Shigella, several studies have revealed that the opp operon is involved in the 
pathogenesis of other bacteria.  In many bacterial species the olgopeptide permease complex is 
involved in quorum sensing, a process to monitor bacterial population density and that may be 
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involved in virulence initiation (9).  In Vibrio fluvialis, another human pathogen, the 
oligopeptide permease operon appears to be involved in biofilm production.  Biofilms are 
formed by aggregates of bacteria that function together to protect one another and that are 
involved in many diseases (10).  Another study revealed a role for the products of the opp
operon in the pathogenesis of group A streptococci, a Gram positive human pathogen (9, 10, 
31). 
b. Cardiolipin synthase (cls)
Cardiolipin synthase is an enzyme that catalyzes the last step in the synthesis of 
cardiolipin, a lipid found in cell membranes (29).  Though Escherichia coli lacking this enzyme 
were found to be less viable when the bacteria have reached maximal density and have an 
increased doubling time, no evidence exists to suggest that cls is a virulence-associated gene in 
E. coli or another bacterial species (29). 
c. Potassium channel (kch)
This channel allows for bacterial uptake of potassium within the host epithelial cell (18).  
The kch gene shares substantial homology with potassium channel genes in eukaryotic cells 
(18).  Although no studies have shown a role in virulence for this potassium channel in Shigella 
species, a study has identified a similar protein, SapG, in Salmonella typhimurium that when 
deleted results in reduced virulence in a mouse model of infection (18). 
d. Putative gene yciI
This gene is poorly characterized.  It may encode a protein involved in cell morphology 
since this is the putative role of a yciI homologue in Haemophilus influenzae (32).  No studies 





Shigellae need to acquire many essential nutrients such as iron to survive. Inside the host 
epithelial cell, Shigellae are dependent on the host cell for these essential nutrients (23, 28).  
There are several iron transport systems that Shigella uses to transport iron from the host 
epithelial cell cytoplasm into the bacterium (23, 28).  TonB-dependent systems are a major type 
of iron transport system used both outside and inside host cells (23).  TonB is involved in the 
transport of iron complexes across the outer bacterial membrane, one of two membranes 
surrounding all Gram negative bacteria.  TonB is associated with outer membrane receptors and 
transduces the energy required to transport iron complexes across the outer membrane (23, 28).   
TonB was shown to be involved in the virulence of several Salmonella species, Vibrio 
species, Pseudomonas species, Haemophilus species, and Escherichia coli (28).  However, a S.
dysenteriae mutant lacking tonB was found to be able to form plaques in a plaque assay, 
indicating that tonB is not responsible for the no-plaque phenotype of SDU380 (4). 
f. Putative operon yciCBA
While yciC  and yciA are uncharacterized, yciB, also called ispA, is a known virulence-
associated gene in S. flexneri (6, 12).  YciB is a putative membrane protein (6, 12). S. flexneri 
lacking yciB were found to have lost the ability to form plaques in a plaque assay, indicating that 
yciB  is essential for S. flexneri virulence (6, 12).  Further analysis of the S. flexneri yciB  mutant 
showed that this strain is avirulent due to a septation (cell division) deficiency as well as an actin 
polymerization deficiency (6, 12).  The inability to properly divide results in the formation of 
long filaments of partially attached bacteria that presumably hinders intercellular spread.  The 
inability to polymerize actin causes the bacteria to be unable to generate the propelling force 
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necessary to spread to neighboring cells (6, 12).  There have been no studies conducted to 
investigate the possible role of yciB (ispA) in S. dysenteriae.
g. Putative gene yciD
This gene encodes a putative outer membrane protein.  In Salmonella, yciD was shown to 
encode a cell envelope protein (24).  There are no studies that have shown a role of yciD in 
bacterial pathogenesis. 
h. Putative gene yciE
This gene codes for a stress protein (11).  Stress proteins are a set of proteins that are 
expressed by organisms under particular stress condition for increased protection of the 
organism and are known to play a role in virulence (22)  
i. Tryptophan Biosynthesis (trp) operon 
This operon also makes up a substantial part of the deletion in SDU380.  As the name 
suggests, the tryptophan biosynthesis operon encodes proteins that are involved in the synthesis 
of the amino acid tryptophan from precursors in the absence of tryptophan in the bacterial 
environment.   
Though there is no evidence suggesting that the tryptophan biosynthesis operon is 
involved in Shigella pathogenesis, a study has shown that tryptophan is involved in the virulence 
of pathogenic E. coli against both Caenorhabditis elegans (microscopic worms) and humans (1).  
Tryptophan, either acquired from the environment or through biosynthesis, was shown to be 
involved in the regulation of Shiga toxin production and of pathogenicity gene expression in 





j. Putative operon yciVO
These two genes are not well characterized.  Crystal structure analysis suggests that yciO 
codes for an RNA binding protein (8).  YciV is a putative enzyme of unknown function.  Neither 
gene is known to play a role in pathogenesis. 
k. Putative gene yciL
This gene is also known as rluB and encodes a pseudouridine synthase, an enzyme that 
catalyzes the conversion of uridine to pseudouridine in RNA molecules, in particular rRNA and 
tRNA (5).  No studies have revealed a role for yciL (rluB) in pathogenesis. 
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E. Purpose of this study 
Given the prevalence of shigellosis and Shigella in developing countries and the recent 
increase of antibiotic resistance among these bacteria, Shigella species have been the subject of 
many studies.  This is particularly true for S. dysenteriae, the leading cause of bacillary 
dysentery epidemics and responsible for a particularly severe form of shigellosis (15).  Shigella 
pathogenesis is one of the main foci of these studies, and one of the main objectives is to 
identify and characterize the genes and proteins involved in Shigella pathogenesis.  The purpose 
of this study is to identify and characterize a novel virulence-associated gene in S. dysenteriae 
through the analysis of the spontaneous avirulent mutant SDU380. 
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II. MATERIALS AND METHODS 
A. Bacterial Strains, Plasmids, and Oligonucleotides 
Bacterial strains used in this study are listed in Table 1.  Table 2 contains a list of 
plasmids used in this study.  Oligonucleotides (primers) used are listed in Table 3.  Primers were 
designed using Clone Manager Professional Software Suite version 8 (Scientific and 
Educational Software, Cary, NC) and synthesized by Integrated DNA Technologies, Coralville, 
IA.  Primers were diluted to 100 µM using distilled water and stored at -20ûC. 
Table 1:  Bacterial strains used in this study
 
Strain name Description Reference or source 
DH5! E. coli strain (27) 
SY327 #pir Contains the prophage 
#pir 
(13) 
MM294 Conjugation helper strain R. Meyer, Univ. Texas, 
Austin 
SDU378 S. dysenteriae Type I 
clinical isolate 
(23) 
SDU380 spontaneous pirazmonam 
resistant SDU380 mutant 
(23) 
0-4576S1 Derivative of S.
dysenteriae clinical isolate 
(14) 
0-4576S1-G spontaneous streptomycin 
resistant 0-4576S1 mutant 
(4) 
0-4576S1-GW spontaneous avirulent 0-
4576S1-G mutant 
E.R.  Murphy, Univ. 
Texas, Austin 
NDS115 0-4576S1-G tonB::cat (4) 
KHS100 0-4576S1-G trpEDC::kan This work 
KHS101 0-4576S1-G oppABC::chl This work 




Table 2: Plasmids used in this study
 
Plasmid Description Reference or source 
pGEM-T Easy Cloning vector Promega 
pHM5 Allelic exchange vector (25) 
pQE2 Expression vector, IPTG 
inducible 
Qiagen 
pKH1 Splice overlap PCR of S.
dysenteriae O-4576S1-
GW trpEDC  cloned into 
pGEM-T Easy 
This work 
pKH2 PCR of S. dysenteriae O-
4576S1-GW oppABC 
cloned into pGEM-T Easy 
This work 
pKH3 Kanamycin resistance 
gene from pUC4K cloned 
into the SmaI site of pKH1 
This work 
pKH5 XbaI EcoRV fragment 
(trpEDC::aph) of pKH3 
cloned into pHM5 
This work 
pKH7 Chloramphenicol 
resistance gene from 
pMTL24Cam cloned into 
the SmaI site of pKH2 
This work 
pKH8 XbaI SphI fragment 
(oppABC::chl) of pKH7 
cloned into pHM5 
This work 
pKH12 Splice overlap PCR of S.
dysenteriae O-4576S1-G 




resistance gene from 
pMTL24Cam cloned into 
the SmaI site of pKH12 
This work 
pKH14 SalI EcoRV fragment 
(yciCBA::chl) of pKH13 
cloned into pHM5 
This work 
pRZ526 Plasmid carrying E. coli 




pND55 Plasmid carrying E. coli 
yciB
N.M.L. Davies, Univ. 
Texas, Austin 
 
Table 3: Primers used in this study
 














B. Media and Growth Conditions 
E. coli strains were cultured in Luria-Bertani broth (LB broth) (10g tryptone, 5g yeast 
extract and 10g NaCl per liter) at 37˚C or grown on Luria-Bertani agar (LB agar) at 37˚C.  S.
dysenteriae strains were cultured in LB broth at 30˚C or at 37˚C or grown on tryptic soy broth 
agar (TSB agar) plus 0.01% Congo red dye at 37˚C. 
Antibiotics were added to LB broth as follows: 250 µg/ml of carbenicillin, 50 µg/ml of 
kanamycin, 35 µg/ml of chloramphenicol, and 200 µg/ml of streptomycin.  Strains containing a 
tonB mutation were supplemented with 40 "M FeSO4.  Isopropyl-#-d-thiogalactosidase (IPTG) 
was used to induce expression of genes cloned behind an inducible plasmid promoter. 
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C. General Molecular Techniques 
1. Recombinant DNA Methods 
The QIAprep Spin Miniprep kit (Qiagen,
 
Santa Clarita, CA) was used to isolate plasmid 
DNA as indicated by the manufacturer.  The QIAquick gel extraction kit (Qiagen) was used to 
isolate DNA fragments from agarose gels as described in the manufacturer’s instructions. 
Enzymes used for endonuclease restriction digests and DNA ligations were purchased 
from New England Biolabs (Beverly, MA) and Promega (Madison, WI).  The reactions were 
performed as described by Sambrook and Russel (27).  HindIII or BstEII digested #DNA was 
used as size markers to estimate DNA fragments separated by gel electrophoresis. 
2. Polymerase Chain Reaction (PCR) 
PCR reactions were carried out in an Applied Biosystems GeneAmp thermocycler or an 
MJ Research PTC-200 thermocycler using Taq polymerase (Qiagen) as indicated the 
manufacturer.  A 100 µL PCR reaction contained the following: template DNA, 5 units of Taq 
polymerase, 10 µM of each primer, 250 µM of each dNTP, and 1x Taq reaction buffer.  Small 
scale 20 µL PCR reactions at the same relative concentrations were carried out for screening 
purposes.  The following PCR program was used: 1) 5 minutes at 94ûC; 2) 30 seconds at 94ûC; 
3) 30 seconds at 50ûC; 4) 1 minute per 1000 bp of expected PCR fragment size at 72ûC; 6) repeat 
steps 2 through 4 29 times; 7) 7 minutes at 72ûC.
3. DNA Sequencing 
Mutations in bacterial strains were verified by DNA sequencing using the automated dye 
termination procedure.  Sequences were analyzed on an ABI 377A DNA sequencer by the Core 
Facility at the Institute for Cellular and Molecular Biology at the University of Texas at Austin. 
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4. Transformation of Bacterial Strains 
a. Electroporation of Shigella
This technique, as described by Sambrook and Russel (26) was used to introduce 
plasmids into electrocompetent bacterial strains.  Bacteria were made electrocompetent as 
follows:  Strains were grown till mid-log at 30ûC in two milliliter LB broth containing 
appropriate antibiotics and chilled on ice for one hour.  Bacteria were harvested by 6000x 
centrifugation at 4ûC for 10 minutes and washed with 25 ml of ice cold water.  Centrifugation 
was repeated and bacteria were washed with 10 ml of ice cold water.  This was repeated one 
more time with 5 ml of ice cold water.  After a final centrifugation bacteria were resuspended in 
250 µL of ice cold water plus 10% glycerol.  One hundred µL of electrocompetent cells were 
used per electroporation.
b. Conjugation
S. dysenteriae mutants were constructed by allelic exchange.  Plasmids were introduced 
into S. dysenteriae by conjugation.  This was achieved by centrifuging one ml each of overnight 
cultures of donor strain containing the plasmid with the mutated allele, recipient strain, and 
helper strain and resuspending each pellet in 100 µL LB broth.  Twenty µL of each suspension 
was mixed and dotted onto an LB agar plate.  The plate was incubated at 37ûC for 6-8 hours.  
The bacteria were collected with a swab and resuspended in 1 ml LB broth.  Bacteria were plated 
onto agar plates containing appropriate antibiotics to select for successful transconjugants. 
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D. Tissue Culture 
Henle cells (intestinal 407 cells) purchased from the American Type
 
Culture Collection, 
Manassas, Va. were used for all cultured cell experiments.  Cells were grown in Henle medium 
(Eagle’s minimum
 
essential medium, 2 mM glutamine,
 
and 10% fetal bovine serum) in a 5% 
CO2 atmosphere at 37°C. 
1. Invasion Assays 
To determine the stage of pathogenesis for which a putative virulence gene is essential, 
invasion assays were performed.  General instructions as described by Hong et al. (6) were 
followed with the following adjustment:  the monolayer of Henle cells was incubated for 15 
minutes following infection before medium containing extracellular bacteria was removed and 
replaced by medium containing 20 µg/ml gentamicin to kill any remaining extracellular bacteria.  
Monolayers were stained with Wright-Giemsa stain (Baxter Scientific Products, McGaw Park, 
Ill.) and observed under the microscope.
2. Plaque Assays 
Plaque assays were performed to infer virulence of S. dysenteriae mutants.  General 
instructions are described by Oaks et al. (17) with the modifications by Hong et al. (6) and the 
following adjustments: monolayers of Henle cells were grown to confluence in 35 mm diameter 
plates (approximately 2×10
6
 cells per plate) and infected with 2×10
4
 bacteria.  Medium was 
removed after 60 minutes and replaced with medium containing 0.45% (weight/volume) glucose 
and 20µg of gentamicin per mL.  Plaque assays were incubated for 48 to 96 hours.  Medium was 
removed and monolayers were stained with Wright-Giemsa stain. 
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E. In vitro Competition Assays 
1. Colony Size Assay 
This assay was used to compare mutant and wild type in vitro growth on LB agar.  
Bacteria were grown overnight and diluted.  Approximately 100 bacteria were plated on LB agar 
and incubated overnight at 37ûC.  Bacteria carrying a complemented plasmid were grown in the 
presence of 0, 1, 10, or 100 µM IPTG.  Using a microscope, the size of 10 colonies per plate was 
measured and the mean was calculated and compared.  
2. End Point Analysis 
This technique was used to compare mutant and wild type in vitro growth in LB broth.  
Three overnight cultures of each bacterial strain were diluted approximately 1:100 so that each 
culture contained an equal number of bacteria.  Bacteria containing a complementing plasmid 
were grown in the presence of 0, 1, 10, or 100 µM IPTG. Cultures were grown at 37ûC for 
approximately 8 hours and absorbance was measured at 600 nm. 
3. Growth Assay 
This technique was used to further investigate in vitro growth rates in LB broth.    
Bacteria were grown as described in the section labeled End Point Analysis with the following 
modifications:  the optical density (A650) of each culture was measured at the 2, 3, 4, 5, 6, 7, and 
24 hours.  Bacteria containing a complementing plasmid were grown in the presence of 1 µM or 
100 µM IPTG. 
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F. Construction of Mutant Strains 
1. KHS100
The S. dysenteriae trp mutant was constructed as follows:  Using primers trp.1 and trp.2 
and primers trp.3 and trp.4, two fragments containing parts of trpE and trpD and parts of trpD 
and trpC were amplified from O4576S1-GW.  The two fragments were combined using overlap-
extension PCR with primers trp.1 and trp.2, creating a SmaI site within trpD.  The resulting PCR 
fragment was cloned into pGEM-T Easy  and designated pKH1.  pHK1 contains a unique XbaI 
site upstream of the cloned fragment and a unique EcoRV site downstream of the fragment.  A 
HincII  fragment of pUC5K carrying the aph gene (Kan resitance) was inserted into the SmaI
site internal to trpD, yielding pKH3.  After double digestion of pKH3 with XbaI  and EcoRV, 
the cloned fragment was inserted into XbaI EcoRV digested pHM5, yielding pKH5.  pKH5 was 
transferred into O4576S1-G via conjugation.  Recombination and allelic replacement was 
confirmed by PCR analysis of sucrose-resistant, carbenicillin-sensitive, kanamycin-resistant 
isolated colonies.  The resulting trpEDC::kan strain was designated KHS100.  DNA sequenc 
analysis verified successful mutant construction.
2. KHS101
The S. dysenteriae opp mutant was contructed as follows: Primers opp.3 and opp.4 were 
used to amplify part of oppA, oppB, and part of oppC from O4576S1-GW.  The resulting PCR 
fragment was cloned into pGEM-T Easy and designated pKH2.  The plasmid contains a SphI 
site downstream of the cloned fragment and a unique XbaI site upstream the fragment in addition 
to a SmaI site internal to oppB.  A SmaI fragment of pMTL24Cam carrying the cat gene (Chl 
resistance) was inserted into the SmaI site in oppB, yielding pKH7.  The cloned fragment 
containing the cat gene was removed from pKH7 using SphI and XbaI and inserted into SphI
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XbaI digested pHM5, yielding pKH8.  pKH8 was transferred into O4576S1-G via conjugation 
and recombination and allelic replacement was confirmed by PCR analysis of sucrose-resistant, 
carbenicillin-sensitive, chloramphenicol -resistant isolated colonies.  The resulting oppABC::chl 
strain was designated KHS101 and DNA sequence analysis verified successful mutant 
construction. 
3. KHS103
The S. dysenteriae yciB mutant was constructed as follows:  Using primers yciB.3 and 
yciB.4 a DNA fragment containing parts of yciC and yciB was amplified from O4576S1-G.  
Another fragment containing part of yciB, yciA, and part of tonB was amplified from O4576S1-
G using primers yciB.5 and yciB.6.  The two fragments were combined using overlap-extension 
PCR with primers yciB.3 and yciB.6, creating a deletion and a SmaI site within yciB.  This PCR 
fragment was cloned into pGEM-T Easy and designated pKH12.   The plasmid contains a 
unique SalI site upstream of the cloned fragment and an EcoRV site downstream of the 
fragment.  A SmaI  fragment of pMTL24Cam carrying the cat gene (Chl resistance) was inserted 
into the SmaI site in yciB, yielding pKH13.  The SalI  and EcoRV  fragment of pKH13 (the 
cloned fragment) was inserted into SalI EcoRV digested pHM5, yielding pKH14. pKH14 was 
transferred into O4576S1-G via conjugation and recombination and allelic replacement was 
confirmed by PCR analysis of sucrose-resistant, carbenicillin-sensitive, chloramphenicol-
resistant isolated colonies.  The resulting yciB::chl strain was designated KHS103.  DNA 





A. Identification of novel virulence gene in S. dysenteriae
1. Background
To identify which of the genes deleted in SDU380 accounts for the loss of ability to form 
plaques, mutants lacking only one gene or one operon were constructed and tested for the ability 
to form plaques in a plaque assay.  The virulence gene could not be identified by simply 
complementing SDU380 with plasmids carrying only one of the genes in the deleted region, 
because SDU380 carries resistance genes to nearly all common antibiotics. 
2. oppABC is not required for plaque formation in S. dysenteriae
A S. dysenteriae oppABC mutant, KHS100, was constructed and tested in a plaque assay.  
The mutant was able to form plaques in similar number and of similar size as the wild type 
parental strain, indicating that the lack of the oligopeptide permease complex in SDU380 was 






Figure 4:  The S. dysenteriae oligopeptide permease mutation is not 
responsible for the no-plaque phenotype of SDU380.
A S. dysenteriae mutant lacking oppABC and the S. dysenteriae wild-type 
parental strain were tested in a plaque assay.  There was no observable 
difference in plaque number and size, indicating that gene(s) other than in the 
oligopeptide permease operon are responsible for the loss of ability of 
SDU380 to form plaques.  
 
3. trpEDC is not required for plaque formation in S. dysenteriae
A S. dysenteriae trpEDC mutant, KHS101, was constructed and tested in a plaque assay.  
The mutant strain was able to form wild-type plaques, indicating that genes other than the ones 
encoding the tryptophan biosynthesis system are responsible for the no-plaque phenotype of 
SDU380 (Fig. 5). 
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Figure 5:  The S. dysenteriae tryptophan biosynthesis deletion is not 
responsible for the no-plaque phenotype of SDU380.
A S. dysenteriae mutant lacking trpEDC and the S. dysenteriae wild-type 
parental strain were tested in a plaque assay.  Both strains formed plaques of 
approximately same size and number, indicating that gene(s) other than in the 
tryptophan biosynthesis operon account for the loss of ability to form plaques 
of SDU380.  
 
4. yciB is a virulence gene is S. dysenteriae
A S. dysenteriae yciB mutant, KHS103, was constructed and tested in a plaque assay.  
The mutant was not able to form plaques, indicating that yciB is a virulence gene (Fig. 6).  
Complementing KHS103 with a plasmid carrying yciB, pND55, restored the ability to form 
plaques when yciB was expressed at low levels (0µM IPTG, 1µM IPTG and 10µM IPTG).  
Overexpression of yciB with 100µM IPTG resulted in loss of ability to form plaques, indicating 




Figure 6: yciB is a S. dysenteriae virulence gene.
A S. dysenteriae mutant lacking yciB and the S. dysenteriae wild-type parental 
strain were tested for virulence in a plaque assay.  The mutant did not form 





Figure 7:  The S. dysenteriae yciB gene is tightly regulated. 
Complementing the S. dysenteriae yciB mutant with yciB restored the ability 
to form plaques when the plasmid was not induced or only slightly induced 
(0µM IPTG, 1µM IPTG, or 10µM IPTG).  Overexpression of yciB in the 
presence of 100µM IPTG did not complement plaque formation. 
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B. Characterization of virulence gene yciB
1. Background
As briefly mentioned in the introduction, yciB is a known virulence gene in S. flexneri.  
A S. flexneri mutant lacking yciB is therefore unable to form plaques and further characterization 
of the mutant revealed that this is likely due to both an intracellular growth defect and an 
intracellular spread defect (12).  The mutant forms long filaments that appear to be unable to 
completely septate.  The mutant is also unable to spread intracellularly, a step in pathogenesis 
that depends on the bacteria’s ability to polymerize actin. 
The loss of ability of the S. dysenteriae mutant to form plaques in a plaque assay 
indicates that yciB is a virulence gene.  Complementation studies of SDU380 with yciB were 
done to determine whether yciB is the only virulence gene in the deleted region and an invasion 
assay was performed to study during which stage of S. dysenteriae pathogenesis YciB is 
essential.
2. YciB complements plaque formation of SDU380 
Complementing SDU380 with a plasmid carrying yciB restored plaque formation if yciB 
was expressed in low levels (0µM IPTG or 1µM IPTG) (Fig. 8).  This indicates that only the 
yciB gene was responsible for the no-plaque phenotype of SDU380.  Expression of yciB at 
higher levels (10µM IPTG or 100µM IPTG) did not complement the plaque phenotype, further 
indicating yciB is highly regulated in S. dysenteriae (Fig. 8). 
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Figure 8:  The S. dysenteriae yciB gene is tightly regulated. 
Complementing SDU380 with yciB restored the ability to form plaques when 
yciB was not induced or only slightly induced (0µM IPTG or 1µM IPTG).  




3. YciB may play an essential role in intracellular replication and/or intercellular 
spread
The yciB mutant KHS103, the wild-type parental strain O4576S1-G, and the mutant 
complemented with pND55 (yciB) in the presence of 1µM IPTG were compared in the invasion 
assay.  Figure 9 shows two representative images per strain at 2, 4, 6, and 8 hours post infection.  
All three strains appear to grow at a similar rate during the first 2 hours after infection.  At the 4 
hour time point, the mutant has multiplied significantly less than either the wild-type strain or 
the mutant strain carrying the complementing plasmid.  While both the wild-type strain and the 
mutant strain carrying the complementing plasmid show signs of intercellular spread at 6 hours 
post-infection, the yciB mutant strain does not.  The number of bacteria in cells at the 8 hour 
time point varies too much for all three strains to draw any conclusions.  This may partially be 
due to increased bacterial death in the overcrowded epithelial cells.  Overall, the mutant appears 
































































































































































































































































































4. A S. dysenteriae yciB mutant shows no in vitro growth defect 
a. Comparison of growth rates of S. dysenteriae yciB mutant and parental 
strain in LB broth showed no significant difference 
In vitro growth of KHS103, O4576S1-G, and KHS103 complemented with pND55 with 
varying amounts of IPTG were compared in an end point analysis and in a growth analysis.  The 
yciB mutant did not show an in vitro growth defect compared to the parental strain O4576S1-G, 
and expression of pND55 with varying amounts of IPTG did not cause a significant difference in 















































Figure 10:  The S. dysenteriae protein YciB does not affect in vitro growth 
No growth defect of KHS103 versus O4576S1-G was observed in an end point 
analysis.  No significant difference in growth between KHS103, O4576S1-G, 
and KHS103 complemented with pND55 in the presence of 0, 1, 10, or 100µM 
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IPTG was observed.  This suggests that YciB is not essential for in vitro growth 
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Figure 11:  YciB does not affect in vitro growth rate 
KHS103, O4576S1-G, and KHS103 complemented with pND55 in the 
presence of 1µM IPTG and 100µM IPTG showed no significant difference in 




b. Comparison of growth of S. dysenteriae yciB mutant and parental strain on 
LB agar showed no significant difference 
Comparing the average colony size of KHS103, O4576S1-G, and KHS103 
complemented with pND55 further suggested that YciB has no in vitro growth effect.  The 
complemented strain was grown on various amounts of IPTG to test if altered expression of yciB 
resulted in a growth defect.  Both KHS103 and O4576S1-G were grown in the presence of no 
IPTG and 5µM IPTG as controls.  While supplementing the complemented KHS103 strain with 
100µM IPTG resulted in significantly smaller colonies compared to no IPTG supplement, all 
strains, including the controls, formed smaller colonies on 5µM IPTG, suggesting that the 
difference observed on 100µM IPTG was a function of increased IPTG amounts, not of 
increased expression of yciB (Fig 12).  Thus, while the level of YciB is important for in vivo 


























































































































































































Figure 12:  Varying the amount of YciB has no effect on colony size
The level of YciB has no effect on average colony sizes of KHS103, 




A. Identification of virulence gene yciB
The purpose of this project was to identify a novel virulence gene by analyzing the 
spontaneous, avirulent mutant SDU380.  SDU380 had sustained a 33 kilobase deletion, and none 
of the genes in the deleted region were known S. dysenteriae virulence genes.   
Three mutants (an oligopeptide permease mutant, a tryptophan biosynthesis mutant, and 
an yciCBA operon mutant) were constructed and tested for virulence in a plaque assay.  The 
oligopeptide permease mutant KHS100 was able to form wild-type plaques, both in terms of 
number and in terms of size, indicating that the oligopeptide permease operon plays no role in S.
dysenteriae invasion, intracellular replication, and intercellular spread, three essential steps in 
Shigella pathogenesis.  Similarly, the tryptophan biosynthesis mutant KHS101 was able to form 
plaques.  Though the wild-type parental strain formed slightly more and slightly bigger plaques, 
there was no significant difference in plaque formation, suggesting that the tryptophan 
biosynthesis operon plays no essential role in the three steps of Shigella pathogenesis.  The yciB 
mutant KHS103 was, however, unable to form plaques, indicating that it is a virulence gene.  
Complementation of KHS103 and SDU380 with yciB restored the wild-type plaque phenotype, 
verifying that yciB is a virulence gene and indicating that yciB is sufficient to restoring plaque 
formation of SDU380.  This further suggests that yciB is the only gene in the deleted region that 
plays a role in S. dysenteriae invasion, intracellular replication, and intercellular spread. 
The expression level of yciB appears to play a role in S. dysenteriae virulence, as was 
shown by the loss of ability to form plaques of the complemented mutant when supplemented 
with high levels of IPTG.  This was both true for complemented KHS103 and complemented 
SDU380, indicating that yciB expression is tightly controlled and consequently suggesting that 
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YciB is very important in S. dysenteriae pathogenesis.  However, the levels of IPTG at which 
plaque formation of the mutant carrying a complementing plasmid could be restored were 
different in KHS103, which could form plaques when yciB was expressed with 0 µM, 1 µM, and 
10 µM IPTG, and SDU380, which could form plaques when yciB was expressed with 0 µM and 
1 µM IPTG.  This difference is likely due to genetic differences other than yciB between the two 
mutant strains.  In other words, genes other than yciB in the deleted region of SDU380 affect 
virulence, but only yciB is essential in restoring ability to form plaques of SDU380. 
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B. Characterization of yciB
While the plaque assay is sufficient to identify a virulence genes, further studies are 
necessary to understand the nature of its involvement in virulence.  An invasion assay was done 
to identify the stage of pathogenesis affected by loss of YciB.  The data suggested that YciB 
affects intracellular growth and intercellular spread.  This conclusion is based on the observation 
that at four hours post-infection infected eukaryotic cells contained fewer numbers of mutant 
bacteria relative to wild-type and mutant carrying a complementing plasmid.  Furthermore, 
while both wild-type and mutant carrying a complementing plasmid showed signs of 
intercellular spread at the six hour time point, KHS103 showed no indication of spread.  There is 
no evidence indicating whether loss of YciB affects these two steps of pathogenesis directly or 
indirectly. 
While both S. flexneri and S. dysenteriae yciB mutants were defective in intracellular 
growth and intercellular spread, the two mutant strains displayed a different phenotype.  The S.
flexneri yciB mutant had a septation defect resulting in long filaments formation (12).  No such 
defect was displayed by the S. dysenteriae yciB mutant.  This difference is not surprising, since 
the two species, despite a similar general lifestyle and similar genetic makeup, are distinct. 
The growth defect of the S. dysenteriae yciB mutant was further studied in vitro.  Neither 
an endpoint analysis nor a growth curve verified the growth defect of KHS103 in vitro.  While 
the colony size assay showed some indication that YciB affects replication rate, as seen by the 
decreasing average colony size with increasing amounts of IPTG and thus presumably yciB 
expression, the data were insufficient to conclude that the growth defect was solely due to YciB 
levels.  A growth defect in vivo but not in vitro is not uncommon and suggests that YciB is 
regulated by a multitude of signals, including specifically intracellular signals. 
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While further analysis is necessary to identify the signals involved in YciB regulation and 
the extent of YciB involvement in S. dysenteriae virulence, this study identified a novel 
virulence gene in S. dysenteriae.  The findings further suggest that YciB affects intracellular 
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